CTSB and brain ischemia: 2-(3′,5′-Dimethoxybenzylidene) cyclopentanone (DMBC), a novel synthetic small-molecule compound, inhibits the release of cathepsin B from the lysosomes into the cytoplasm after cerebral ischemia, thereby protecting neurons against ischemic injury [92].